Novartis Lays Off 60 Workers at Flatiron Biotech Post-Acquisition
SOURCENews reportView the filing ↗
What we know
Location: New York, NY, USA.
Department affected: biotech.
Based on news reporting.
Summary
Novartis has laid off 60 workers at its Flatiron biotech division following its $1.4 billion acquisition of the company. This decision reflects the company's strategic adjustments post-acquisition as it integrates Flatiron into its operations. The layoffs are part of a broader effort to streamline the workforce and enhance efficiency within the newly acquired entity. The affected employees were primarily based in New York, where Flatiron's headquarters is located. This move underscores the challenges and changes that often accompany large-scale acquisitions in the biotech industry.
Novartis East Hanover cut 60 jobs in NY affecting its biotech team as of June 22, 2026.
That is roughly 0.1% of the 110,000 people Novartis East Hanover employs.
LayoffTalk has tracked 24 layoff events at Novartis East Hanover since March 2025, including 234 jobs documented in official WARN filings, with 20 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Novartis East Hanover
Recent tracked events at this company.
Recent layoffs in NY
Other companies with tracked events in the same state.